payday loans
payday loans
Skip to content

Accueil FMC Grippe A (H1N1) European Medicines Agency Reaffirms Efficacy And Safety Of H1N1v Pandemic Vaccines
European Medicines Agency Reaffirms Efficacy And Safety Of H1N1v Pandemic Vaccines PDF Imprimer Envoyer
The European Medicines Agency has reviewed further data on the centrally authorised pandemic vaccines, Celvapan, Focetria and Pandemrix. The Agency has reaffirmed their positive balance of benefits and risks in the context of the current H1N1v influenza pandemic. The data on Focetria and Pandemrix indicate that a single dose of these vaccines is able to trigger an immune response that may be sufficient to give protection against the H1N1v pandemic influenza in some age groups. (Source: Immune System / Vaccines News From Medical News Today)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.


Author:

Read Full Article
 

find-us-on-facebook-2

United4LungHealth

image001

World Allergy Week 2017 The Agony of Hives

WCOPDday2017



PubMed Logo
Word

 To: 

Langtolang Dictionary

CNP2014Ebook

50x50_firefoxsafari_iconGchrome


Notre site est optimisé pour les Navigateurs suivants : Firefox, Safari et Google Chrome. Cliquez sur l'un des logos ci-dessus pour le télécharger et l'installer gratuitement.

Tabac

Accueil FMC Grippe A (H1N1) European Medicines Agency Reaffirms Efficacy And Safety Of H1N1v Pandemic Vaccines Top